EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome

Kazutoshi Fujita, Makoto Matsushita, Marco A De Velasco iD, Koji Hatano, Takafumi Minami, Norio Nonomura, Hirotsugu Uemura iD

Cancers · 21.02.2023 · 15 (5) · 1375

DOI: 10.3390/cancers15051375 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.02.2023. Verfasst von Kazutoshi Fujita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kindai University Faculty of Medicine, Osakasayama 589-8511, Japan. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, The Japanese Urological Association, Yakult Bio-Science Foundation..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity and a high-fat diet are risk factors associated with prostate cancer, and lifestyle, especially diet, impacts the gut microbiome. The gut microbiome plays important roles in the development of several diseases, such as Alzheimer’s disease, rheumatoid arthritis, and colon cancer. The analysis of feces from patients with prostate cancer by 16S rRNA sequencing has uncovered various associations between altered gut microbiomes and prostate cancer. Gut dysbiosis caused by the leakage of gut bacterial metabolites, such as short-chain fatty acids and lipopolysaccharide results in prostate cancer growth. Gut microbiota also play a role in the metabolism of androgen which could affect castration-resistant prostate cancer. Moreover, men with high-risk prostate cancer share a specific gut microbiome and treatments such as androgen-deprivation therapy alter the gut microbiome in a manner that favors prostate cancer growth. Thus, implementing interventions aiming to modify lifestyle or altering the gut microbiome with prebiotics or probiotics may curtail the development of prostate cancer. From this perspective, the “Gut–Prostate Axis” plays a fundamental bidirectional role in prostate cancer biology and should be considered when screening and treating prostate cancer patients.

Schlagwörter

Stichwörter der Autor:innen

castration resistant prostate cancergutmicrobiomemicrobiotaprostate cancer

Autor:innen und Institutionen

  • Department of Urology, Kindai University Faculty of Medicine, Osakasayama 589-8511, Japan.
  • Department of Urology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
  • Department of Genome Biology, Kindai University Faculty of Medicine, Osakasayama 589-8511, Japan.

ORCID-Profile: Marco A De Velasco, Hirotsugu Uemura

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • The Japanese Urological Association
  • Yakult Bio-Science Foundation.
  • Japanese Urological Association, KAKENHI
  • Yakult Bio-Science Foundation

Zitieren

APA

Fujita, K., Matsushita, M., De Velasco, M. A., Hatano, K., Minami, T., Nonomura, N., & Uemura, H. (2023). The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome. Cancers, 15(5), 1375. https://doi.org/10.3390/cancers15051375

Vancouver

Fujita K, Matsushita M, De Velasco MA, Hatano K, Minami T, Nonomura N, et al. The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome. Cancers. 2023;15(5):1375. doi:10.3390/cancers15051375

BibTeX
@article{Fujita2023,
  author = {Fujita, Kazutoshi and Matsushita, Makoto and De Velasco, Marco A and Hatano, Koji and Minami, Takafumi and Nonomura, Norio and Uemura, Hirotsugu},
  title = {The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1375},
  doi = {10.3390/cancers15051375}
}
Kostenlos starten →